148 related articles for article (PubMed ID: 38253656)
21. [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].
Chen H; Huang Q; Zhai DZ; Dong J; Wang AD; Lan Q
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):484-8. PubMed ID: 18069625
[TBL] [Abstract][Full Text] [Related]
22.
Patel CB; Fazzari E; Chakhoyan A; Yao J; Raymond C; Nguyen H; Manoukian J; Nguyen N; Pope W; Cloughesy TF; Nghiemphu PL; Czernin J; Lai A; Ellingson BM
J Neurooncol; 2018 Sep; 139(2):399-409. PubMed ID: 29679199
[TBL] [Abstract][Full Text] [Related]
23. Effects of artery input function on dynamic contrast-enhanced MRI for determining grades of gliomas.
Jia L; Wu X; Wan Q; Wan L; Jia W; Zhang N
Br J Radiol; 2021 Mar; 94(1119):20200699. PubMed ID: 33332981
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
25. Whole-brain amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging in glioma patients using low-power steady-state pulsed chemical exchange saturation transfer (CEST) imaging at 7T.
Heo HY; Jones CK; Hua J; Yadav N; Agarwal S; Zhou J; van Zijl PC; Pillai JJ
J Magn Reson Imaging; 2016 Jul; 44(1):41-50. PubMed ID: 26663561
[TBL] [Abstract][Full Text] [Related]
26. Metabolic and hemodynamic evaluation of gliomas using positron emission tomography.
Tyler JL; Diksic M; Villemure JG; Evans AC; Meyer E; Yamamoto YL; Feindel W
J Nucl Med; 1987 Jul; 28(7):1123-33. PubMed ID: 3496433
[TBL] [Abstract][Full Text] [Related]
27. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
Jacobs AH; Thomas A; Kracht LW; Li H; Dittmar C; Garlip G; Galldiks N; Klein JC; Sobesky J; Hilker R; Vollmar S; Herholz K; Wienhard K; Heiss WD
J Nucl Med; 2005 Dec; 46(12):1948-58. PubMed ID: 16330557
[TBL] [Abstract][Full Text] [Related]
28. High level of Sema3C is associated with glioma malignancy.
Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
[TBL] [Abstract][Full Text] [Related]
29. [Intraoperative fluorescence control with chlorin E6 in resection of glial brain tumors].
Rynda AY; Olyushin VE; Rostovtsev DM; Zabrodskaya YM; Tastanbekov MM; Papayan GV
Zh Vopr Neirokhir Im N N Burdenko; 2021; 85(4):20-28. PubMed ID: 34463447
[TBL] [Abstract][Full Text] [Related]
30. Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.
Di Stefano AL; Bergsland N; Berzero G; Farina L; Rognone E; Gastaldi M; Aquino D; Frati A; Tomasello F; Ceroni M; Marchioni E; Bastianello S
Biomed Res Int; 2014; 2014():154350. PubMed ID: 24800207
[TBL] [Abstract][Full Text] [Related]
31. ¹⁸F-Fluoromisonidazole positron emission tomography may differentiate glioblastoma multiforme from less malignant gliomas.
Hirata K; Terasaka S; Shiga T; Hattori N; Magota K; Kobayashi H; Yamaguchi S; Houkin K; Tanaka S; Kuge Y; Tamaki N
Eur J Nucl Med Mol Imaging; 2012 May; 39(5):760-70. PubMed ID: 22307533
[TBL] [Abstract][Full Text] [Related]
32. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative
Unterrainer M; Fleischmann DF; Vettermann F; Ruf V; Kaiser L; Nelwan D; Lindner S; Brendel M; Wenter V; Stöcklein S; Herms J; Milenkovic VM; Rupprecht R; Tonn JC; Belka C; Bartenstein P; Niyazi M; Albert NL
Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1368-1380. PubMed ID: 31486876
[TBL] [Abstract][Full Text] [Related]
33. Quartile histogram assessment of glioma malignancy using high b-value diffusion MRI with a continuous-time random-walk model.
Karaman MM; Zhang J; Xie KL; Zhu W; Zhou XJ
NMR Biomed; 2021 Apr; 34(4):e4485. PubMed ID: 33543512
[TBL] [Abstract][Full Text] [Related]
34. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas.
Kawai N; Lin W; Cao WD; Ogawa D; Miyake K; Haba R; Maeda Y; Yamamoto Y; Nishiyama Y; Tamiya T
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1870-8. PubMed ID: 24781871
[TBL] [Abstract][Full Text] [Related]
35. The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades.
Wang M; Wang T; Liu S; Yoshida D; Teramoto A
Brain Tumor Pathol; 2003; 20(2):65-72. PubMed ID: 14756443
[TBL] [Abstract][Full Text] [Related]
36. Application of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET imaging to predict highly malignant tumor grades and hypoxia-inducible factor-1α expression in patients with glioma.
Tateishi K; Tateishi U; Sato M; Yamanaka S; Kanno H; Murata H; Inoue T; Kawahara N
AJNR Am J Neuroradiol; 2013 Jan; 34(1):92-9. PubMed ID: 22700754
[TBL] [Abstract][Full Text] [Related]
37. The in vitro motility of human gliomas increases with increasing grade of malignancy.
Chicoine MR; Silbergeld DL
Cancer; 1995 Jun; 75(12):2904-9. PubMed ID: 7773941
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
Fan YX; Luo RC; Li GP; Zheng H; Huang K
Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
[TBL] [Abstract][Full Text] [Related]
39. Comparison of Different Post-Processing Algorithms for Dynamic Susceptibility Contrast Perfusion Imaging of Cerebral Gliomas.
Kudo K; Uwano I; Hirai T; Murakami R; Nakamura H; Fujima N; Yamashita F; Goodwin J; Higuchi S; Sasaki M
Magn Reson Med Sci; 2017 Apr; 16(2):129-136. PubMed ID: 27646457
[TBL] [Abstract][Full Text] [Related]
40. Mean apparent propagator-MRI in evaluation of glioma grade, cellular proliferation, and IDH-1 gene mutation status.
Sun Y; Su C; Deng K; Hu X; Xue Y; Jiang R
Eur Radiol; 2022 Jun; 32(6):3744-3754. PubMed ID: 35076759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]